Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $50.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments